IBM Healthcare North America

Global Pharmaceutical Manufacturer

Risk Management · Supply Chain Optimization

A global pharmaceutical manufacturer needed faster, more standardized supply-chain risk analysis because manual classification, fragmented documentation, and limited visibility into alternate suppliers and materials slowed decisions and reduced resilience.

>1500 risk events assessed, triaged and escalated to executives as needed
>95% reduction in decision cycle time, with proactive highlighting of risks and improved visibility across the supply chain network
No global events that resulted in stock-out of top products in 2025

Reported impact

Business outcome

The manufacturer cut supply-chain decision time from weeks to days, assessed and escalated large volumes of risk events, prevented stock-outs in top products, and improved agility and transparency across its network.

  • Productivity Improvement
  • Risk Reduction
  • Scalability

Solution

The manufacturer worked with IBM Consulting to build a modular risk-orchestration platform on the IBM watsonx AI portfolio and AWS cloud services. The solution unifies data from execution, planning, procurement, logistics, and third-party risk providers so teams can ask natural-language questions and review a common set of risk signals instead of compiling reports manually. Within that platform, generative AI supports multidimensional risk analysis, automated gap identification, and summarized risk correlation, while a virtual assistant uses an LLM text-to-SQL capability to answer supply-chain questions, handle unsupported-query exceptions, and provide bilingual access. The system surfaces at-risk suppliers and sites, maps bills of materials, shows 12-month inventory projections, highlights revenue exposure, and suggests alternate sites or materials. That architecture turns scattered risk monitoring into a real-time decision layer for executives and supply-chain teams.

Data flow

Execution, planning, procurement, logistics, and third-party risk data are consolidated into the watsonx-based platform on AWS, where generative AI analyzes correlations, an LLM interface answers natural-language questions and text-to-SQL requests, and the resulting risk alerts, impact views, and alternate-supply recommendations are escalated to executives and planners.

Solution architecture

3 components · 2 layers
  1. Compute
    • IBM watsonx Provides the AI foundation for risk analysis, summarization, and natural-language interrogation of supply-chain data.
  2. Orchestration
    • IBM watsonx Orchestrate Supports the orchestration of modular risk workflows and executive escalations across the supply chain.
    • AWS cloud services Hosts the scalable risk-orchestration platform that integrates supply-chain and third-party risk data.

Architecture clues

  • The LLM interface includes text-to-SQL and bilingual support.
  • The platform projects inventory impacts over the next 12 months.
  • The system can suggest alternate sites or materials to meet demand.

Evidence from the source

The manufacturer partnered with IBM Consulting to co-create a scalable and modular supply chain risk orchestration platform, built with the IBM watsonx AI portfolio and AWS cloud services.
They also introduced a gen AI-powered virtual assistant featuring a natural language interface for querying supply chain data.
Unifying data across execution, planning, procurement, logistics and third-party risk providers facilitated natural language queries (NLQ) to deliver actionable insights.
more than a 95% reduction in decision cycle time
over 1.500 risks were assessed, triaged and escalated to executives as needed
Transparency Evidence & methodology 90/100 reference value · 89% confidence · 1 source

Review how this reference was scored and trace each normalized claim back to its documented source.

01

Scoring methodology

How scores are calculated

Customer Reference Value measures usefulness as a customer reference. Evidence Confidence measures the quality and traceability of available evidence, not independent verification.

Customer reference value90/100
  • Problem clarity20/20
    Measures whether the customer's operational problem is specific enough to compare.
  • Implementation depth25/25
    Rewards named components, data flow, integrations, and architecture detail.
  • Outcome specificity20/20
    Measures whether the reported benefit is concrete rather than a generic claim.
  • Quantified impact15/25
    1 metric describe measurable impact.
  • Deployment scale10/10
    Rewards evidence of a live or scaled deployment and meaningful integration scope.
Evidence confidence89%
  • Source authority20/25
    The main evidence is an official vendor-published customer story.
  • Claim traceability21/25
    10 of 12 key fields link to a named source.
  • Direct evidence20/20
    5 direct source quotes retained.
  • Date provenance10/10
    The publication date comes from the source page or publisher.
  • Source transparency8/10
    1 source reference document publisher, URL, authority, retrieval, and supported fields.
  • Implementation specificity10/10
    Rewards source-backed components, data flow, quantified impact, and a specific outcome.
02

Traceability

Sources & provenance

Field coverage shows which facts each source supports. Dates are shown only when documented by the source.

  1. IBM

    Global Pharmaceutical Manufacturer customer story

    First-party
    https://www.ibm.com/case-studies/global-pharmaceutical-manufacturer
    Source type
    Vendor-published customer story
    Published
    Dec 10, 2025
    Supports
    • Customer
    • Business problem
    • Solution
    • Products
    • Solution components
    • Data flow
    • Integrations
    • technical area
    • use case category
    • Business outcome
    • outcome category
    • Metrics
    • Architecture
    • evidence quotes
    • Publication date

Date evidence

Not separately sourced Industry, Region, Company size. Treat these normalized attributes as lower-confidence until a dedicated source is added.